Stock HUM HUMANA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Humana Inc.

Equities

HUM

US4448591028

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
358.1 USD +3.09% Intraday chart for Humana Inc. +2.53% -21.78%
May. 31 ANALYST RECOMMENDATIONS : Humana, Netapp, Dell, Qualcomm, Paypal... Our Logo
May. 30 Baird Initiates Humana at Neutral Rating With $374 Price Target MT

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

  • The company shows low valuation levels, with an enterprise value at 0.43 times its sales.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Managed Healthcare

1st Jan change Capi. Investor Rating ESG Refinitiv
HUMANA INC. Stock Humana Inc.
-21.78% 43.15B
A-
UNITEDHEALTH GROUP INC. Stock UnitedHealth Group Inc.
-5.91% 456B
B-
ELEVANCE HEALTH, INC. Stock Elevance Health, Inc.
+14.19% 125B
A-
CIGNA Stock Cigna
+15.08% 97.9B
B-
CENTENE CORPORATION Stock Centene Corporation
-3.53% 38.2B
B-
MOLINA HEALTHCARE, INC. Stock Molina Healthcare, Inc.
-12.93% 18.43B
B-
PROGYNY, INC. Stock Progyny, Inc.
-27.51% 2.57B
C+
ALIGNMENT HEALTHCARE, INC. Stock Alignment Healthcare, Inc.
-8.59% 1.5B
B-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. HUM Stock
  4. Ratings Humana Inc.